Valuation: Boston Scientific Corporation

Market Cap 69.19B 59.92B 55.86B 51.37B 96.99B 6,579B 98.07B 656B 258B 3,292B 260B 254B 10,902B P/E 2026 *
17.9x
P/E 2027 * 18.6x
Enterprise Value 77.9B 67.47B 62.9B 57.85B 109B 7,408B 110B 739B 290B 3,706B 293B 286B 12,275B EV / Sales 2026 *
3.65x
EV / Sales 2027 * 3.34x
Free-Float
82.5%
Yield 2026 *
-
Yield 2027 * -
1 day+3.32%
1 week+3.69%
Current month+2.16%
1 month+5.76%
3 months-14.72%
6 months-38.51%
Current year-49.93%
1 week 44.43
Extreme 44.43
49.49
1 month 42.2
Extreme 42.2
49.49
Current year 42.2
Extreme 42.2
100.9
1 year 42.2
Extreme 42.2
109.5
3 years 42.2
Extreme 42.2
109.5
5 years 34.98
Extreme 34.98
109.5
10 years 19.67
Extreme 19.67
109.5
Manager TitleAgeSince
Chief Executive Officer 61 01/11/2011
Director of Finance/CFO 52 30/06/2025
Chief Tech/Sci/R&D Officer - 01/09/2009
Director TitleAgeSince
Chairman 61 03/05/2016
Director/Board Member 74 01/03/2014
Director/Board Member 74 15/04/2016
Date Insider Type Main position Quantity % Market Cap.
31/07/26 Other

Executive/Senior Manager

64,198 0.0043%
31/07/26 Buy

Director

5,000 0.0003%
01/07/26 Fiscal year

Chief Financial Officer

5,184 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-2.75%+3.69%-54.46%-5.88% 69.19B
+2.32%+0.24%+23.89%+5.32% 214B
+2.51%+1.61%+0.31%-21.63% 140B
+1.88%+6.26%-21.34%+21.30% 133B
-0.70%+3.74%+12.28%+11.84% 51.28B
+0.17%+5.70%-13.79%-19.41% 50.43B
+1.37%+0.58%+22.82%+11.73% 39.85B
+0.99%+5.41%+42.25%+37.98% 39.27B
+0.40%+4.55%-21.39%+24.98% 32.32B
-0.03%-2.31%-0.71%-7.46% 31.73B
Average +1.13%+3.16%-1.01%+5.88% 80.06B
Weighted average by Cap. +1.59%+2.83%+0.42%+3.34%

Financials

2026 *2027 *
Net sales 21.37B 18.51B 17.25B 15.87B 29.95B 2,032B 30.29B 203B 79.56B 1,017B 80.25B 78.48B 3,367B 22.34B 19.35B 18.03B 16.59B 31.31B 2,124B 31.66B 212B 83.18B 1,063B 83.89B 82.04B 3,520B
Net income 3.84B 3.33B 3.1B 2.85B 5.39B 365B 5.45B 36.46B 14.31B 183B 14.43B 14.12B 606B 3.74B 3.24B 3.02B 2.78B 5.24B 356B 5.3B 35.47B 13.92B 178B 14.04B 13.73B 589B
Net Debt 8.72B 7.55B 7.04B 6.47B 12.22B 829B 12.36B 82.7B 32.46B 415B 32.74B 32.02B 1,374B 5.45B 4.72B 4.4B 4.05B 7.64B 518B 7.73B 51.72B 20.3B 259B 20.48B 20.02B 859B
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (66%): products used in cardiology surgeries (35% of net sales), electrophysiology tests (25.1%) cardiac rhythm management (17.6%), peripheral surgeries (7.5%), and other (14.8%); - endodontic surgery (28%): equipment used in endoscopy (51.8% of net sales), and urology (48.2%) ; - neuromodulation (6%). Net sales are distributed geographically as follows: the United States (64.1%), Europe/Middle East/Africa (17.2%), Asia/Pacific (15.4%) and other (3.3%).
Employees
59,000
Date Price Change Volume
05/08/26 $47.74 -2.75% 16,512,147
04/08/26 $49.09 +1.36% 21,565,121
03/08/26 $48.43 +3.64% 20,379,998
31/07/26 $46.73 +1.59% 18,691,884
30/07/26 $46.00 -0.09% 25,894,477
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
47.74USD
Average target price
62.69USD
Spread / Average Target
+31.31%

Quarterly revenue - Rate of surprise